Alternatives to Trijardy XR If You Can't Fill Your Prescription

When your pharmacy can't fill a Trijardy XR prescription, the situation can feel stressful — especially when you rely on it to manage type 2 diabetes. The good news is that because Trijardy XR is a combination of three well-established medications, there are several alternatives that can bridge the gap while you locate your medication or work with your doctor on a longer-term plan. This guide covers your main options.

Understanding What's in Trijardy XR

Before exploring alternatives, it helps to know what you'd be replacing. Trijardy XR combines three active ingredients:

• Empagliflozin (SGLT2 inhibitor) — lowers blood sugar by making the kidneys excrete excess glucose in urine; also reduces cardiovascular death risk
• Linagliptin (DPP-4 inhibitor) — increases incretin hormones to stimulate insulin release after meals
• Metformin extended-release (biguanide) — reduces the amount of sugar your liver produces and improves insulin sensitivity

Any alternative will either replicate one of these components, two of them, or all three through separate pills. Talk to your prescriber before making any changes.

Option 1: Synjardy XR (Empagliflozin + Metformin ER)

Synjardy XR is also made by Boehringer Ingelheim and contains empagliflozin plus extended-release metformin — two of the three ingredients in Trijardy XR. It's taken once daily with breakfast and is FDA-approved for type 2 diabetes and cardiovascular risk reduction. If you're switching from Trijardy XR to Synjardy XR, your doctor would typically prescribe a separate linagliptin tablet (Tradjenta) to cover the missing DPP-4 inhibitor component. This option preserves the cardiovascular benefit of empagliflozin.

Option 2: Glyxambi (Empagliflozin + Linagliptin)

Glyxambi combines empagliflozin and linagliptin — exactly two of the three ingredients in Trijardy XR — without metformin. If your doctor decides to continue both the SGLT2 inhibitor and DPP-4 inhibitor, Glyxambi plus separate metformin (which is widely available generically at very low cost) can replicate the full effect of Trijardy XR. This option is also made by Boehringer Ingelheim and maintains the cardiovascular protection of empagliflozin.

Option 3: Jardiance (Empagliflozin Alone)

Jardiance is the standalone empagliflozin tablet. If your primary reason for taking Trijardy XR includes the cardiovascular risk reduction benefit, Jardiance is the most direct alternative for that indication. Your doctor would add separate prescriptions for a DPP-4 inhibitor and/or metformin as needed. Note that Jardiance has also been facing supply pressure due to its expanded indications — so it's worth checking availability before assuming it's in stock.

Option 4: Janumet XR (Sitagliptin + Metformin ER)

Janumet XR is a DPP-4 inhibitor (sitagliptin) plus metformin ER combination. It doesn't contain an SGLT2 inhibitor, so it lacks the cardiovascular and renal benefits of empagliflozin. However, a generic version (sitagliptin/metformin ER) became available in the U.S. after January 2023, making it significantly more affordable. For patients whose primary need is blood sugar control without the cardiovascular indication, Janumet XR or its generic equivalent may be a more accessible and cost-effective bridge option.

Option 5: Farxiga (Dapagliflozin)

Farxiga (dapagliflozin) is another SGLT2 inhibitor — a different drug in the same class as empagliflozin. It's FDA-approved for type 2 diabetes, heart failure with reduced ejection fraction, and chronic kidney disease. If empagliflozin is unavailable and your doctor determines you need an SGLT2 inhibitor, Farxiga is considered clinically equivalent for many of these indications. It's often better stocked than empagliflozin-containing products. Your doctor would manage the metformin and DPP-4 inhibitor components separately.

Option 6: GLP-1 Receptor Agonists (Ozempic, Trulicity, Rybelsus)

For some patients, a GLP-1 receptor agonist like semaglutide (Ozempic, Rybelsus) may be clinically appropriate as an alternative or addition to other diabetes medications. GLP-1 agonists lower blood sugar, reduce cardiovascular events, and support weight loss. These are often used in combination with metformin. However, GLP-1 agonists have their own availability challenges, so discuss with your doctor whether this is practical in your situation.

Important: Never Stop Your Diabetes Medication Without Talking to Your Doctor

If you cannot fill Trijardy XR, do not simply stop taking it without medical guidance. Stopping abruptly can cause your blood sugar to rise, which can be dangerous. Call your prescriber's office as soon as you know there is a supply problem — they can quickly call in a bridge prescription or arrange samples.

Before switching medications, it's also worth trying all options to locate Trijardy XR at a pharmacy near you. See our guide on how to find Trijardy XR in stock near you, or use medfinder to check which pharmacies in your area can fill it today.